• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Revised autism screening tool (M-CHAT-R/F) may allow for earlier diagnosis

byLeah Carr, MD
December 24, 2013
in Pediatrics
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. The Modified Checklist for Autism in Toddlers Revised with Follow-Up (M-CHAT-R/F) is an effective and reliable test for detecting autism spectrum disorder (ASD) that requires little time and cost to administer. 

2. The M-CHAT-R/F detected ASD at a significantly higher rate than the M-CHAT and allowed for ASD diagnosis by age 2, 2 years earlier than the median age of diagnosis of 4 years. 

Evidence Rating Level: 2 (Good)           

Study Rundown: Autism spectrum disorder (ASD) is characterized by communication and social interaction deficits along with restrictive and repetitive behaviors. As early intervention is known to improve long-term outcomes, the American Academy of Pediatrics (AAP) recommends autism-specific screenings at 18- and 24-month well-child care visits. One widely-used screening tool is a parent-report questionnaire called the Modified Checklist for Autism in Toddlers (M-CHAT). The current study sought to validate the revised version of the M-CHAT (M-CHAT-R) with a follow-up component, the M-CHAT Revised with Follow-Up (M-CHAT-R/F).Through this prospective study, the M-CHAT-R/F was determined to be a valid screening test, detecting ASD at a significantly higher rate than the M-CHAT and allowing for ASD diagnosis by age 2. There are several limitations to this study. First, it is possible that screen-negatives could have been missed at final diagnosis, therefore altering calculated “misses” and testing sensitivity. Also, some parents of children who initially screened positive did not complete the entire study course. Nevertheless, data from this study suggest that the M-CHAT-R/F is an effective and reliable screening tool for ASDs in a low-risk pediatric sample. Steps must be taken to ease its implementation at well-child visits.

Click to read the study published today in Pediatrics

Relevant Reading: Identification and Evaluation of Children with Autism Spectrum Disorders

RELATED REPORTS

Preclinical detectable phase for open-angle glaucoma estimated at 10 years

Rate of childhood vision screening decreased substantially between 2016 and 2020

Religious attendance may be correlated with cancer screening utilization

Study Author, Dr. Diana L. Robins, PhD, talks to 2 Minute Medicine: Associate Professor of Psychology and Neuroscience, Georgia State University.

“Autism spectrum disorders (ASD) are severe developmental disorders. However, children who receive intensive early intervention have the best prognosis. Standardized ASD-specific screening can reduce the age of ASD detection by two years, compared to the national median age of diagnosis. The Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F) is a 2-stage screening tool designed for use during toddler well-child care visits to pediatricians and other healthcare providers. Parents complete initial questions in about 5 minutes, and if results indicate ASD risk, parents complete the Follow-Up questions. Of children who continue to show ASD risk on the 2-stage M-CHAT-R/F, 95% are diagnosed with a developmental delay or concern about development, including ASD. This highlights the confidence physicians and healthcare providers have that referrals are needed when children screen positive on the 2-stage M-CHAT-R/F.”

In-Depth [prospective cohort study]: A total of 15 612 toddlers in metropolitan Atlanta or Conneticut were included in this study (mean age = 20.95 + 3.30 months, 7570 female). Of this group, 263 children screened positive for ASD and underwent a thorough diagnostic evaluation. First, parents completed the M-CHAT-R/F and those whose children screened positive were then contacted by telephone to complete the follow up, which consisted of structured questions with a clinician. Continued positive screens resulted in a full diagnostic evaluation. Across all M-CHAT-R items, internal consistency was below the threshold for adequate (*Cronbach’s α = .63), although when the 2-stage screen was examined, internal consistency was adequate (Cronbach’s α = .79). Of children with a total score on the screening tool of ≥3 initially and ≥2 at follow-up, 47.5% were diagnosed with ASD and 94.6% had some developmental delay or other concerns. Total score was more effective than alternative scores. The M-CHAT-R/F detected ASD at a significantly higher rate than the M-CHAT (67 cases per 10,000 using the M-CHAT-R/F vs. 45 cases per 10,000 using the M-CHAT; X2 = 8.63; P = .003) and allowed for ASD diagnosis by age 2.

*Cronbach’s α is a coefficient of internal consistency used to measure the reliability of a psychometric test. For example, an α value ≥ 0.9 could indicate “excellent” internal consistency, 0.7-0.9 is “good”, 0.6-0.7 is “acceptable”, 0.5-0.6 is “poor”, and α < 0.5 is “unacceptable.”

By Cordelia Y. Ross and Leah H. Carr

More from this author: AAP policy supports consumption of only pasteurized dairy products; Pregnancy and peripartum risk factors associated with childhood ADHD; Consistent parenting linked to lower child BMI; Cough medicine-related ED visits linked to unsupervised ingestion; Shared decision-making associated with increased parental resistance to vaccinations

©2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: autismautism spectrum disordersscreening
Previous Post

2 Minute Medicine Rewind December 16-22, 2013

Next Post

Peripregnancy nut consumption may decrease development of nut allergies

RelatedReports

Roux-en-Y gastric bypass may slow progression of diabetic retinopathy
2 Minute Medicine

Preclinical detectable phase for open-angle glaucoma estimated at 10 years

December 5, 2022
Roux-en-Y gastric bypass may slow progression of diabetic retinopathy
2 Minute Medicine

Rate of childhood vision screening decreased substantially between 2016 and 2020

October 5, 2022
Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease
Oncology

Religious attendance may be correlated with cancer screening utilization

March 25, 2022
#VisualAbstract Patient-led surveillance after treatment of localized melanoma is safe, feasible, and acceptable compared to clinician-led surveillance
StudyGraphics

#VisualAbstract Patient-led surveillance after treatment of localized melanoma is safe, feasible, and acceptable compared to clinician-led surveillance

December 3, 2021
Next Post
Peripregnancy nut consumption may decrease development of nut allergies

Peripregnancy nut consumption may decrease development of nut allergies

Classics Series, Landmark Trials in Medicine

PROS network study examines pubertal onset by race/ethnic groups [Pediatrics Classics Series]

Classics Series, Landmark Trials in Medicine

Low-lead exposure in childhood associated with worse cognitive performance [Pediatrics Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Spirituality may promote mental health recovery for people with schizophrenia in Southeast Asia
  • #VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa
  • Patients with early pregnancy loss less likely to receive active management in the emergency department
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options